Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Tibor Fekete"'
Autor:
Katalin Mangó, Ferenc Fekete, Ádám Ferenc Kiss, Réka Erdős, János Tibor Fekete, Tamás Bűdi, Edit Bruckner, Miklós Garami, Tamás Micsik, Katalin Monostory
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Cyclophosphamide, an oxazaphosphorine prodrug is frequently used in treatment of neuroblastoma, which is one of the most prevalent solid organ malignancies in infants and young children. Cytochrome P450 2B6 (CYP2B6) is the major catalyst and
Externí odkaz:
https://doaj.org/article/a924d8b47e904dffb98b704562f02c80
Autor:
Tibor Fekete, János, Győrffy, Balázs
Publikováno v:
In Computational and Structural Biotechnology Journal 2022 20:2885-2894
Autor:
János Tibor Fekete, Balázs Győrffy
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 20, Iss , Pp 2885-2894 (2022)
Intro: In vitro cell line models provide a valuable resource to investigate compounds useful in the systemic chemotherapy of cancer. However, the due to the dispersal of the data into several different databases, the utilization of these resources is
Externí odkaz:
https://doaj.org/article/888f6f54648d46bfa5729579d311d604
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Attila Lehotzky, Judit Oláh, János Tibor Fekete, Tibor Szénási, Edit Szabó, Balázs Győrffy, György Várady, Judit Ovádi
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
The pathological association of alpha-synuclein (SYN) and Tubulin Polymerization Promoting Protein (TPPP/p25) is a key factor in the etiology of synucleinopathies. In normal brains, the intrinsically disordered SYN and TPPP/p25 are not found together
Externí odkaz:
https://doaj.org/article/04f1ddc3853b4d3880713103d797d208
Autor:
Javier Pérez-Pena, Janos Tibor Fekete, Raquel Páez, Mariona Baliu-Piqué, José Ángel García-Saenz, Vanesa García-Barberán, Aránzazu Manzano, Pedro Pérez-Segura, Azucena Esparis-Ogando, Atanasio Pandiella, Balázs Gyorffy, Alberto Ocana
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Limited therapeutic options exist for the treatment of patients with triple negative breast cancer (TNBC). Neoadjuvant chemotherapy is currently the standard of care treatment in the early stages of the disease, although reliable biomarkers of respon
Externí odkaz:
https://doaj.org/article/2b97967ba8f142d7bb90ed522f622601
Publikováno v:
Acta Pharmacologica Sinica.
Immune-checkpoint inhibitors show promising effects in the treatment of multiple tumor types. Biomarkers are biological indicators used to select patients for a systemic anticancer treatment, but there are only a few clinically useful biomarkers such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e48c087b98bab7e7798985e85c95bcd4
https://doi.org/10.1038/s41401-023-01079-6
https://doi.org/10.1038/s41401-023-01079-6
Autor:
János Tibor Fekete, Balázs Győrffy
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 2; Pages: 1508
The overall response rate to fluoropyrimidine monotherapy in colorectal cancer (CRC) is limited. Transcriptomic datasets of CRC patients treated with 5-fluorouracil (5FU) could assist in the identification of clinically useful biomarkers. In this res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a92368e9983d683ec485c3bf74fac4
Autor:
Jozsef Lazar, Peter Antal-Szalmas, Istvan Kurucz, Annamaria Ferenczi, Mihaly Jozsi, Ilona Tornyi, Monika Muller, Janos Tibor Fekete, John Lamont, Peter FitzGerald, Anna Gall-Debreceni, Janos Kadas, Andras Vida, Nadege Tardieu, Yann Kieffer, Anne Jullien, Mariana Guergova-Kuras, William Hempel, Andras Kovacs, Tamas Kardos, Nora Bittner, Eszter Csanky, Maria Szilasi, Gyorgy Losonczy, Klara Szondy, Gabriella Galffy, Edit Csada, Klara Szalontai, Attila Somfay, David Malka, Paul Cottu, Krisztina Bogos, Laszlo Takacs
Publikováno v:
Molecular & Cellular Proteomics. :100580
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42def8de0604bb835e2cfe6444bebc84
https://doi.org/10.1016/j.mcpro.2023.100580
https://doi.org/10.1016/j.mcpro.2023.100580
Publikováno v:
Carcinogenesis
Despite advances in molecular characterization of glioblastoma multiforme (GBM), only a handful of predictive biomarkers exist with limited clinical relevance. We aimed to identify differentially expressed genes in tumor samples collected at surgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::948253405084d7d07b88ed535341ad64
http://europepmc.org/articles/PMC8215594
http://europepmc.org/articles/PMC8215594